X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (11550) 11550
Book Review (4715) 4715
Publication (773) 773
Book Chapter (43) 43
Conference Proceeding (13) 13
Book / eBook (10) 10
Magazine Article (7) 7
Newsletter (5) 5
Newspaper Article (5) 5
Dissertation (3) 3
Data Set (2) 2
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (10118) 10118
humans (9569) 9569
placebo-controlled trial (5492) 5492
double-blind (4731) 4731
male (4498) 4498
female (4200) 4200
pharmacology & pharmacy (3837) 3837
adult (3431) 3431
middle aged (2890) 2890
placebo (2805) 2805
double-blind method (2554) 2554
treatment outcome (2345) 2345
placebos (2290) 2290
aged (2004) 2004
pharmacokinetics (1615) 1615
efficacy (1609) 1609
drug therapy (1603) 1603
animals (1549) 1549
psychiatry (1515) 1515
clinical trials (1365) 1365
clinical neurology (1364) 1364
adolescent (1277) 1277
care and treatment (1262) 1262
dose-response relationship, drug (1197) 1197
safety (1157) 1157
medicine & public health (1147) 1147
abridged index medicus (1096) 1096
neurosciences (1087) 1087
research (1074) 1074
randomized controlled-trial (946) 946
clinical trials as topic (887) 887
analysis (876) 876
drug therapy, combination (802) 802
pharmacotherapy (790) 790
randomized controlled trials as topic (770) 770
internal medicine (769) 769
medicine, general & internal (766) 766
dosage and administration (762) 762
health aspects (756) 756
administration, oral (739) 739
young adult (736) 736
child (733) 733
therapy (719) 719
drug administration schedule (714) 714
time factors (694) 694
pharmacology/toxicology (683) 683
cross-over studies (643) 643
oncology (625) 625
pharmacology (601) 601
risk factors (557) 557
pain (549) 549
drug interactions (546) 546
children (523) 523
immunology (515) 515
review (494) 494
studies (492) 492
quality-of-life (491) 491
pediatrics (479) 479
aged, 80 and over (474) 474
prevention (473) 473
drugs (471) 471
medical research (467) 467
usage (452) 452
medicine, research & experimental (448) 448
placebo effect (444) 444
patients (443) 443
toxicology (440) 440
drug dosages (439) 439
endocrinology & metabolism (433) 433
trial (422) 422
cancer (416) 416
neurology (403) 403
prospective studies (391) 391
schizophrenia (388) 388
complications and side effects (379) 379
antidepressants (376) 376
management (373) 373
medicine (370) 370
tolerability (370) 370
gastroenterology & hepatology (365) 365
multicenter (361) 361
rheumatology (353) 353
infectious diseases (352) 352
article (346) 346
antipsychotic agents - therapeutic use (339) 339
surgery (337) 337
quality of life (335) 335
severity of illness index (335) 335
anticonvulsants - therapeutic use (331) 331
antidepressive agents - therapeutic use (322) 322
depression (322) 322
area under curve (306) 306
open-label (305) 305
pharmacodynamics (302) 302
physiological aspects (300) 300
psychopharmacology (299) 299
diabetes mellitus, type 2 - drug therapy (297) 297
treatment (291) 291
rheumatoid arthritis (285) 285
mortality (281) 281
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (11469) 11469
German (44) 44
Spanish (34) 34
French (33) 33
Russian (10) 10
Polish (4) 4
Italian (3) 3
Korean (3) 3
Portuguese (2) 2
Danish (1) 1
Dutch (1) 1
Japanese (1) 1
Norwegian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Sexually Transmitted Diseases, ISSN 0148-5717, 02/2010, Volume 37, Issue 2, pp. 100 - 104
Journal Article
Journal Article
Journal Article
Clinical and Experimental Pharmacology and Physiology, ISSN 0305-1870, 10/2006, Volume 33, Issue 10, pp. 917 - 924
SUMMARY • Non-steroidal anti-inflammatory drugs (NSAIDs) cause renal side-effects. In the present study, we tested the hypothesis that the extent of the renal... 
pharmacokinetics | kidney | non-steroidal anti-inflammatory drugs | cyclo-oxygenase-2 | sodium urinary excretion | cyclo‐oxygenase‐2 | non‐steroidal anti‐inflammatory drugs | Cyclo-oxygenase-2 | Pharmacokinetics | Kidney | Non-steroidal anti-inflammatory drugs | Sodium urinary excretion | GASTROINTESTINAL TOXICITY | PHYSIOLOGY | CYCLOOXYGENASE-2 | RAT | HYPERKALEMIA | PROTEIN-BINDING | MELOXICAM | INTERSPECIES DIFFERENCES | GENTAMICIN | NONSTEROIDAL ANTIINFLAMMATORY DRUGS | PHARMACOLOGY & PHARMACY | Thiazoles - blood | Area Under Curve | Thiazines - administration & dosage | Thiazines - adverse effects | Sulfones - adverse effects | Male | Thiazoles - administration & dosage | Anti-Inflammatory Agents, Non-Steroidal - blood | Thiazoles - adverse effects | Thiazoles - pharmacokinetics | Dose-Response Relationship, Drug | Cyclooxygenase 2 Inhibitors - adverse effects | Sulfonamides - blood | Lactones - blood | Lactones - pharmacokinetics | Sodium - urine | Lactones - administration & dosage | Pyrazoles - blood | Pyrazoles - pharmacokinetics | Sulfones - blood | Placebos - administration & dosage | Pyrazoles - adverse effects | Thiazines - pharmacokinetics | Kidney - drug effects | Administration, Oral | Cyclooxygenase 2 Inhibitors - administration & dosage | Rats | Thiazines - blood | Celecoxib | Lactones - adverse effects | Placebos - pharmacokinetics | Sulfones - pharmacokinetics | Cyclooxygenase 2 Inhibitors - pharmacokinetics | Rats, Sprague-Dawley | Sulfonamides - pharmacokinetics | Pyrazoles - administration & dosage | Animals | Anti-Inflammatory Agents, Non-Steroidal - adverse effects | Potassium - urine | Anti-Inflammatory Agents, Non-Steroidal - pharmacokinetics | Sulfonamides - adverse effects | Sulfonamides - administration & dosage | Sulfones - administration & dosage | Kidney, drug effects | Lactones, adverse effects | Sulfones, administration and dosage | Thiazoles, administration and dosage | Anti-Inflammatory Agents, Non-Steroidal, pharmacokinetics | Anti-Inflammatory Agents, Non-Steroidal, adverse effects | Sodium, urine | Thiazines, blood | Anti-Inflammatory Agents, Non-Steroidal, blood | Lactones, administration and dosage | Cyclooxygenase 2 Inhibitors, adverse effects | Pyrazoles, blood | Sulfonamides, pharmacokinetics | Thiazines, pharmacokinetics | Pyrazoles, administration and dosage | Thiazoles, blood | Sulfonamides, administration and dosage | Cyclooxygenase 2 Inhibitors, administration and dosage | Lactones, pharmacokinetics | Sulfonamides, blood | Cyclooxygenase 2 Inhibitors, pharmacokinetics | Thiazines, adverse effects | Lactones, blood | Thiazoles, adverse effects | Thiazoles, pharmacokinetics | Sulfones, blood | Sulfonamides, adverse effects | Thiazines, administration and dosage | Placebos, pharmacokinetics | Sulfones, pharmacokinetics | Pyrazoles, adverse effects | Placebos, administration and dosage | Potassium, urine | Sulfones, adverse effects | Pyrazoles, pharmacokinetics | Index Medicus
Journal Article
Clinical Drug Investigation, ISSN 1173-2563, 10/2013, Volume 33, Issue 10, pp. 727 - 736
Journal Article
British Journal of Clinical Pharmacology, ISSN 0306-5251, 01/2018, Volume 84, Issue 1, pp. 64 - 78
AimWe compared the pharmacokinetic (PK) profiles of co-crystal of tramadol-celecoxib (CTC) vs. each reference product (alone and in open combination) after... 
co‐crystal | pharmacokinetics | tramadol | pain | celecoxib | co-crystal | PLACEBO | MANAGEMENT | ARTHROPLASTY | IBUPROFEN | PARECOXIB SODIUM | CONCISE GUIDE | PHARMACOLOGY | DOUBLE-BLIND | POSTOPERATIVE DENTAL PAIN | PHARMACOLOGY & PHARMACY | COMBINATION ANALGESICS | Clinical trials | Nonsteroidal anti-inflammatory drugs | Index Medicus | Pharmacokinetics
Journal Article
Cancer Epidemiology Biomarkers & Prevention, ISSN 1055-9965, 10/2008, Volume 17, Issue 10, pp. 2619 - 2624
Journal Article
Journal Article
Journal Article